Inventurus Knowledge Solutions share price
NSE: IKSBSE: 544309IT - ServicesSmall Cap
Inventurus Knowledge Solutions Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2024 · Issue price ₹1,329
Last close ₹1,703.80down ₹7.10 (0.42%)BSE ₹1,707.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,710.90.
30 Oct: open ₹1,700.00, high ₹1,725.30, low ₹1,678.90
52-week range of traded prices to 30 Oct 2026
₹1,262.00Low, 23 Mar 2026₹1,970.00High, 23 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹29,233 Cr290th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.27
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 10.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 33.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 29.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.23
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 86,56265.3% delivered
About Inventurus Knowledge Solutions
Inventurus Knowledge Solutions, which trades as IKS Health, runs a care enablement platform that takes administrative, clinical and operational work off hospitals, health systems and physician groups in the United States.123 It handles tasks such as billing, medical coding, prior authorisation (getting an insurer's approval before treatment), documentation and scheduling, combining its own software and AI with expert staff who check the AI's decisions.4
The business is organised in solution suites: revenue cycle management (billing, coding and collecting payment), clinical support solutions such as AI-assisted medical scribing, and value-based care, which helps providers turn data into outcomes on risk, quality and total cost of care.5 Its products include the Scribble range of scribing tools, MyCareHub, Autonomous Coding, TruCode, Stacks, AssuRx and Optimix.65 Its operations are mainly in the US and India, with a presence in Canada and Australia.1
IKS Health was founded in 2006 by Sachin K. Gupta, its Founder and Global CEO, and is headquartered in Mumbai.17 It bought Aquity, a clinical documentation business, in 2023, and its shares were listed on the stock exchanges on 19 Dec 2024.28 Its promoter group held 63.72% of the company at the end of March 2026.9
Inventurus Knowledge Solutions key points
Results
- In the quarter to Jun 2026, revenue from operations rose 20.7% to ₹8,936 million and EBITDA (earnings before interest, tax, depreciation and amortisation) rose 24.0% to ₹2,949 million, a 33% margin after one-time acquisition costs. Profit after tax rose 27.8% to ₹1,937 million.1011
- In the year to Mar 2026, consolidated revenue rose 20% to ₹3,194 crore and profit after tax rose 48%.12
- Free cash flow (cash from operations left after tax and spending on equipment and software) was ₹6,129 million in the year to Mar 2026, up 122.5%.13
Market position
- IKS Health says it supports about 150,000 clinicians, about 18% of all US physicians, through more than 600 client organisations.14
- TruBridge, the company's hospital record business, has more than 30% market share in the small-hospital segment, the company says.15
- Black Book Research rated IKS Health first in AI-driven revenue cycle management in its 2025 and 2026 awards.16
TruBridge acquisition
- On 9 Jul 2026, IKS Inc, the company's US subsidiary, completed the purchase of all of TruBridge, an electronic health record (digital patient files) and revenue cycle management business serving rural and community hospitals, for $557 million.1718
- TruBridge's record system is installed in more than 700 hospitals and holds more than 5 million patient records, which the company is building into a training set for its own AI.19
- The company says 70% of TruBridge's electronic health record clients do not yet use revenue cycle management services, and puts the immediately addressable market within TruBridge's client base at $600 million.20
- For the deal, IKS Inc has taken or is to take financing facilities of up to $635,000,000 from lenders; the company says its starting leverage (debt measured against a year's EBITDA) rises to about 3 times EBITDA.2122
Customers and partners
- The 10 largest customers made up 53.8% of revenue in the quarter to Jun 2026, against 43.4% a year earlier.23
- More than 85% of revenue comes from repeat customers, and the company counts more than 450 enterprise-level customers.2425
- The 10 largest clients have worked with the company for 5.76 years on average, and the 5 largest for 7.41 years.25
- Among its deal wins for the quarter, existing client Advocate Health is expanding its revenue cycle and coding work with the company across its network of hospitals and clinics.26
Workforce
Products and technology
- The company holds US patent 12,619,923 for its Engagement Learning Engine, the behavioural model behind its patient access products, including MyCareHub.28
- In the year to Mar 2026, the company launched Scribble Select, which lets clinicians switch between fully automatic AI scribing and human-checked notes, and MyCareHub, which automates patient engagement and financial clearance.29
- Its autonomous coding (software that assigns billing codes to medical records) reaches 89% automation and more than 88% accuracy in certain specialities, the company says.30
What the company expects
- The company stated in its annual report for the year to Mar 2026 that it aims to triple EBITDA to ₹3,000 crore by the year to Mar 2030.31
Recent events
- On 5 Aug 2026, IKS Inc, the company's US subsidiary, agreed to sell 54,055 Series A-1 preferred shares of Abridge AI Inc to Alpha Square Group Fund IV for $10,000,175.3233
- On 19 Jun 2026, CARE Ratings assigned the company an issuer rating (its view of the company's general ability to repay debt) of CARE A+ with a stable outlook.34
- On 14 May 2026, the company completed the purchase of 10,000 equity shares of ARAI Solutions, which adds biomedical knowledge graphs (databases linking medical facts) to its AI, for ₹11,00,00,000.3536
Last updated
All 36 sources, each with its page
- 1. Annual report, 28 Aug 2026, page 27
- 2. Annual report, 28 Aug 2026, page 7
- 3. Annual report, 28 Aug 2026, page 52
- 4. Annual report, 28 Aug 2026, page 8
- 5. Annual report, 28 Aug 2026, page 13
- 6. Annual report, 28 Aug 2026, page 12
- 7. Annual report, 28 Aug 2026, page 5
- 8. Annual report, 28 Aug 2026, page 47
- 9. Annual report, 28 Aug 2026, page 47
- 10. Investor presentation, 5 Aug 2026, page 10
- 11. Investor presentation, 5 Aug 2026, page 9
- 12. Annual report, 28 Aug 2026, page 6
- 13. Annual report, 28 Aug 2026, page 16
- 14. Annual report, 28 Aug 2026, page 27
- 15. Annual report, 28 Aug 2026, page 11
- 16. Annual report, 28 Aug 2026, page 19
- 17. Exchange filing, 9 Jul 2026, page 1
- 18. Annual report, 28 Aug 2026, page 7
- 19. Annual report, 28 Aug 2026, page 27
- 20. Annual report, 28 Aug 2026, page 11
- 21. Exchange filing, 10 Jul 2026, page 1
- 22. Annual report, 28 Aug 2026, page 16
- 23. Investor presentation, 5 Aug 2026, page 15
- 24. Investor presentation, 5 Aug 2026, page 4
- 25. Investor presentation, 5 Aug 2026, page 9
- 26. Investor presentation, 5 Aug 2026, page 12
- 27. Annual report, 28 Aug 2026, page 14
- 28. Investor presentation, 5 Aug 2026, page 6
- 29. Annual report, 28 Aug 2026, page 10
- 30. Annual report, 28 Aug 2026, page 11
- 31. Annual report, 28 Aug 2026, page 16
- 32. Exchange filing, 6 Aug 2026, page 1
- 33. Exchange filing, 6 Aug 2026, page 2
- 34. Exchange filing, 19 Jun 2026, page 1
- 35. Exchange filing, 14 May 2026, page 1
- 36. Annual report, 28 Aug 2026, page 11
Results
Consolidated; ₹ crore.Inventurus Knowledge Solutions quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹894 Crup 4.19%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹194 Crdown 5.94%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 21.7%
Revenue by quarter
Peak revenue ₹894 Cr, quarter to Jun 2026; lowest ₹657 Cr, quarter to Dec 2024
Net profit by quarter, a loss in red
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 657 | 724 | 740 | 781 | 815 | 858 | 894 |
| Net profit | 130 | 148 | 152 | 181 | 183 | 206 | 194 |
| Net margin | 19.7% | 20.4% | 20.5% | 23.1% | 22.5% | 24.0% | 21.7% |
Consolidated. The 7 quarters from Dec 2024, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹3,194 Crup 19.89%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹722 Crup 48.45%
- Net margin
- 22.6%
Revenue by year
Peak revenue ₹3,194 Cr, year to Mar 2026; lowest ₹2,664 Cr, year to Mar 2025
Net profit by year, a loss in red
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 2,664 | 3,194 |
| Net profit | 486 | 722 |
| Net margin | 18.2% | 22.6% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, CARE ENABLEMENT PLATFORM PROVIDING TECHNOLOGY ENABLED SOLUTIONS TO HEALTHCARE PROVIDERS, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Inventurus Knowledge Solutions PE ratio and valuation
Price to earnings
At or below today's level on 18% of 247 trading days over the last year.
LowestHighest
Its median40.53Industry median17.34
Price to book
At or below today's level on 22% of 247 trading days over the last year.
LowestHighest
Its median11.15Industry median1.64
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −13.1% | +49.2% | −41.8% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Mutual fund holdings
78 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 45 of the 52 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 1 more fund filed its first portfolio on record, holding it.All 78 funds holding Inventurus Knowledge Solutions
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 3
- AddedAdded. Funds that held more shares than at the end of the month before.
- 31
- CutCut. Funds that held fewer shares than at the end of the month before.
- 21
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 22
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 1
| Fund | |||
|---|---|---|---|
 Axis Small Cap FundAxis Mutual Fund | 10,36,929 | 0.59% | ₹181.2 Cr |
 Edelweiss Small Cap FundEdelweiss Mutual Fund | 6,50,131 | 1.62% | ₹113.6 Cr |
 Aditya Birla Sun Life Midcap FundAditya Birla Sun Life Mutual Fund | 4,45,073 | 1.19% | ₹77.8 Cr |
 ICICI Prudential Technology FundICICI Prudential Mutual Fund | 4,39,604 | 0.61% | ₹76.8 Cr |
 Tata Balanced Advantage FundTata Mutual Fund | 4,39,544 | 0.96% | ₹76.8 Cr |
 Mirae Asset Flexi Cap FundMirae Asset Mutual Fund | 2,49,900 | 1.00% | ₹43.7 Cr |
 ITI Small Cap FundITI Mutual Fund | 2,03,323 | 0.97% | ₹35.5 Cr |
 Invesco India Flexi Cap FundInvesco Mutual Fund | 1,71,204 | 0.55% | ₹29.9 Cr |
 Union Flexi Cap FundUnion Mutual Fund | 1,65,243 | 1.24% | ₹28.9 Cr |
| Union Innovation & Opportunities FundUnion Mutual Fund | 1,56,148 | 2.09% | ₹27.3 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 31 Oct 2025.Inventurus Knowledge Solutions insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Directors and key managers0 purchases, 12 salesNo purchase₹67 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹67 Cr3 off-market moves
- Employees0 purchases, 1 saleNo purchase₹0.09 CrNet−₹0.09 Cr1 off-market move
- Others0 purchases, 31 salesNo purchase₹73 CrNet−₹73 Cr13 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Inventurus Knowledge Solutions competitors and peers
IT Enabled Services, 113 listed companies, priced on 30 Oct 2026. The table lists the 8 companies closest to Inventurus Knowledge Solutions in market cap.IT companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 L&T Technology ServicesLTTS | 45,407 | 29.49 | 6.41 | +2.4% | +20.5% | 23.2% | 25.6% | 1.40% |
 Tata TechnologiesTATATECH | 26,276 | 46.67 | 6.86 | +21.9% | −18.8% | 15.2% | 17.6% | 1.81% |
 Netweb Technologies IndiaNETWEB | 24,805 | 67.80 | 11.79 | +174.9% | +170.6% | 27.3% | 20.5% | 0.07% |
 SagilitySAGILITY | 19,699 | 19.19 | 1.93 | +28.5% | +28.5% | 10.7% | 12.9% | 0.59% |
 Affle 3iAFFLE | 19,308 | 38.84 | 4.57 | +20.3% | +18.5% | 13.3% | 12.6% | 0.00% |
 Black BoxBBOX | 14,150 | 62.61 | 11.00 | +12.2% | +5.1% | 22.1% | 23.1% | 0.13% |
 ESDS Software SolutionESDS | 13,596 | – | – | – | – | – | – | 0.00% |
 Amagi Media LabsAMAGI | 11,901 | – | 6.77 | – | – | – | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Inventurus Knowledge Solutions announcements
Oct 2026
Sep 2026
25 Sep · Analysts
23 Sep · Analysts
21 Sep · Meeting
15 Sep · Analysts
Inventurus Knowledge Solutions annual report, year to Mar 2026
Inventurus Knowledge Solutions share price by year
Each calendar year to 2025.Inventurus Knowledge Solutions share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,657.80 | −13.6% | 1,973.95 | 1,333.05 |
| 2024 | 1,919.50 | – | 2,145.70 | 1,885.80 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 19 Dec 2024.
Recent sessions
The 9 trading days to 29 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 29 Oct 2026 | 1,685.50 | 1,725.00 | 1,679.60 | 1,710.90 | 1,707.51 | 55,910 | 65.3% |
| 28 Oct 2026 | 1,703.00 | 1,711.20 | 1,673.10 | 1,692.80 | 1,688.78 | 68,357 | 59.5% |
| 27 Oct 2026 | 1,651.20 | 1,710.00 | 1,650.00 | 1,703.00 | 1,693.46 | 82,401 | 64.8% |
| 26 Oct 2026 | 1,605.60 | 1,670.30 | 1,585.60 | 1,659.90 | 1,627.52 | 95,709 | 59.6% |
| 23 Oct 2026 | 1,635.20 | 1,656.20 | 1,582.50 | 1,618.00 | 1,608.67 | 2,34,204 | 61.8% |
| 22 Oct 2026 | 1,620.00 | 1,658.00 | 1,598.10 | 1,648.00 | 1,633.70 | 1,41,580 | 55.0% |
| 21 Oct 2026 | 1,675.00 | 1,698.90 | 1,613.00 | 1,631.70 | 1,658.02 | 3,04,182 | 69.5% |
| 19 Oct 2026 | 1,745.80 | 1,745.80 | 1,678.00 | 1,685.80 | 1,699.26 | 68,271 | 56.1% |
| 16 Oct 2026 | 1,718.40 | 1,740.00 | 1,705.20 | 1,731.40 | 1,728.28 | 54,839 | 54.4% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- IKS
- BSE code
- 544309
- ISIN
- INE115Q01022
- Industry
- IT - Services
- Website
- www.ikshealth.com
- CIN
- L72200MH2006PLC337651
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2006
- Registered office
- Building No. 5 & 6, Unit No. 801, Mindspace SEZ, 8th Floo, Thane Belapur Road, Airoli, Thane, Navi Mumbai 400708, Maharashtra
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, BSE 500, Nifty Smallcap 250, BSE 250 SmallCap Index, Nifty Smallcap 100, BSE MidCap